Use of miRNAs as Biomarkers in Sepsis

Analytical Cellular Pathology

Volumn 2015, Issue , 2015, Pages

  Dumache, Raluca ^a   Rogobete, Alexandru Florin ^a,b,c   Bedreag, Ovidiu Horea ^a,b   Sarandan, Mirela ^b   Cradigati, Alina Carmen ^b   Papurica, Marius ^a,b   Dumbuleu, Corina Maria ^b   Nartita, Radu ^c   Sandesc, Dorel ^a,b  

^a VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^b Clinical Emergency County Hospital Pius Brinzeu Timisoara   (Romania)

^c WEST UNIVERSITY OF TIMISOARA   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT; CYTOKINE; MICRORNA; MICRORNA 101; MICRORNA 10B; MICRORNA 1228; MICRORNA 126; MICRORNA 134; MICRORNA 135A; MICRORNA 141; MICRORNA 145; MICRORNA 150; MICRORNA 16; MICRORNA 182; MICRORNA 185; MICRORNA 200C; MICRORNA 203; MICRORNA 205; MICRORNA 20A; MICRORNA 26A; MICRORNA 381; MICRORNA 589; MICRORNA 616; MICRORNA 622; MICRORNA 658; MICRORNA 801; MICRORNA 873; MICRORNA 923; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

BODY FLUID; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; HUMORAL IMMUNITY; INFECTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; ANIMAL; BLOOD; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANIMALS; BIOMARKERS; BODY FLUIDS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; SEPSIS;

EID: 84953898101     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.1155/2015/186716     Document Type: Review

References (99)

1. R. Sonneville, F. Verdonk, C. Rauturier et al., "Understanding brain dysfunction in sepsis, " Annals of Intensive Care, vol. 3, no. 1, article 15, pp. 1-11, 2013.
2. S. D. Tranča, C. L. Petrişor, and N. Haʇa, "Biomarkers in polytrauma induced systemic inflammatory response syndrome and sepsis-A narrative review, " Romanian Journal of Anaesthesia and Intensive Care, vol. 21, no. 2, pp. 118-122, 2014.
3. M. Sinha, S. Mantri, S. Desai, and A. Kulkarni, "Procalcitonin as an adjunctive biomarker in sepsis, " Indian Journal of Anaesthesia, vol. 55, no. 3, pp. 266-270, 2011.
4. Z. Wang, H. Luo, X. Pan, M. Liao, and Y. Hou, "A model for data analysis of microRNA expression in forensic body fluid identification, " Forensic Science International: Genetics, vol. 6, no. 3, pp. 419-423, 2012.
5. A. Perfetti, S. Greco, E. Bugiardini et al., "Plasma microRNAs as biomarkers for myotonic dystrophy type 1, " Neuromuscular Disorders, vol. 24, no. 6, pp. 509-515, 2014.
6. K. Abdelmohsen, S. Srikantan, M.-J. Kang, and M. Gorospe, "Regulation of senescence by microRNA biogenesis factors, " Ageing Research Reviews, vol. 11, no. 4, pp. 491-500, 2012.
7. L. Meng, L. Chen, Z. Li, Z.-X. Wu, and G. Shan, "Roles of MicroRNAs in the Caenorhabditis elegans nervous system, " Journal of Genetics and Genomics, vol. 40, no. 9, pp. 445-452, 2013.
8. J. Starega-Roslan, J. Krol, E. Koscianska et al., "Structural basis of microRNA length variety, " Nucleic Acids Research, vol. 39, no. 1, pp. 257-268, 2011.
9. X. Sun, B. Icli, A. K. Wara et al., "MicroRNA-181b regulates NF-B-mediated vascular inflammation, " Journal of Clinical Investigation, vol. 122, no. 6, pp. 1-18, 2012.
10. F. Borel, P. Konstantinova, and P. L. M. Jansen, "Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma, " Journal of Hepatology, vol. 56, no. 6, pp. 1371-1383, 2012.
11. Y. Huang, X. Lü, Y. Qu, Y. Yang, and S. Wu, "MicroRNA sequencing andmolecularmechanisms analysis of the effects of gold nanoparticles on human dermal fibroblasts, " Biomaterials, vol. 37, pp. 13-24, 2015.
12. K. Jones, J.P. Nourse, C. Keane, A. Bhatnagar, and M.K. Gandhi, "Plasma microRNA are disease response biomarkers in classical hodgkin lymphoma, " Clinical Cancer Research, vol. 20, no. 1, pp. 253-264, 2014.
13. D. Lenkala, E. R. Gamazon, B. LaCroix, H. K. Im, and R. S. Huang, "MicroRNA biogenesis and cellular proliferation, " Translational Research, 2015.
14. C. Roderburg, M. Luedde, D. Vargas Cardenas et al., "Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis, " PLoS ONE, vol. 8, no. 1, Article ID e54612, 2013.
15. G. Williams, M. L. Uchimoto, N. Coult, D. World, and E. Beasley, "Body fluid mixtures: resolution using forensic microRNA analysis, " Forensic Science International: Genetics Supplement Series, vol. 4, no. 1, pp. e292-e293, 2013.
16. A. Etheridge, I. Lee, L. Hood, D. Galas, and K. Wang, "Extracellular microRNA: a new source of biomarkers, " Mutation Research, vol. 717, no. 1-2, pp. 85-90, 2011.
17. J. F. Barger and P. S. Nana-Sinkam, "MicroRNA as tools and therapeutics in lung cancer, " Respiratory Medicine, vol. 109, no. 7, pp. 803-812, 2015.
18. G. Rabinowits, C. Gerçel-Taylor, J. M. Day, D. D. Taylor, and G. H. Kloecker, "Exosomal microRNA: a diagnostic marker for lung cancer, " Clinical Lung Cancer, vol. 10, no. 1, pp.42-46, 2009.
19. Z. Wang, Z. Ruan, Y. Mao et al., "miR-27a is up regulated and promotes inflammatory response in sepsis, " Cellular Immunology, vol. 290, no. 2, pp. 190-195, 2014.
20. I. Summerer, M. Niyazi, K. Unger et al., "Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients, " Radiation Oncology, vol. 8, no. 1, article 296, 2013.
21. P. Rajan, I. M. Sudbery, M. E. M. Villasevil et al., "Nextgeneration sequencing of advanced prostate cancer treated with androgen-deprivation therapy, " European Urology, vol. 66, no. 1, pp. 32-39, 2014.
22. L. Wang, J. Yu, J. Xu, C. Zheng, X. Li, and J. Du, "The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues, " Gene, vol. 554, no. 1, pp. 1-8, 2015.
23. C. Mistrellides, K. Lunnon, M. Sattlecker et al., "MicroRNA biomarkers in Alzheimers disease, " Alzheimers & Dementia, vol. 9, no. 4, supplement, p. P224, 2013.
24. M. M. Harraz, T. M. Dawson, and V. L. Dawson, "MicroRNAs in Parkinsons disease, " Journal of Chemical Neuroanatomy, vol. 42, no. 2, pp. 127-130, 2011.
25. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., "Circulating microRNAs as stable blood-based markers for cancer detection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513-10518, 2008.
26. A.S. Ho, X. Huang, H. Caoet al., "CirculatingmiR-210asanovel hypoxia marker in pancreatic cancer, " Translational Oncology, vol. 3, no. 2, pp. 109-113, 2010.
27. J. Wang, J. Chen, P. Chang et al., "MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel bloodbased biomarkers of disease, " Cancer Prevention Research, vol. 2, no. 9, pp. 807-813, 2009.
28. L. Lin, Y. Lin, Y. Jin, and C. Zheng, "Microarray analysis of microRNA expression in liver cancer tissues and normal control, " Gene, vol. 523, no. 2, pp. 158-160, 2013.
29. P. J. Mishra, "MicroRNAs as promising biomarkers in cancer diagnostics, " Biomarker Research, vol. 2, article 19, 4 pages, 2014.
30. Q. Wang, Z. Huang, S. Ni et al., "Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer, " PLoS ONE, vol. 7, no. 9, Article ID e44398, 2012.
31. I.-P. Yang, H.-L. Tsai, C.-W. Huang et al., "The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse, " PLoS ONE, vol. 8, no. 6, Article ID e66842, 2013.
32. M. Tsujiura, D. Ichikawa, S. Komatsu et al., "Circulating microRNAs in plasma of patients with gastric cancers, " British Journal of Cancer, vol. 102, no. 7, pp. 1174-1179, 2010.
33. Y. Toiyama, Y. Okugawa, and A. Goel, "DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer, " Biochemical and Biophysical Research Communications, vol. 455, no. 1-2, pp. 43-57, 2014.
34. G. H. Kim, "MicroRNA regulation of cardiac conduction and arrhythmias, " Translational Research, vol. 161, no. 5, pp. 381-392, 2013.
35. P. W. Stather, N. Sylvius, J. B. Wild, E. Choke, R. D. Sayers, and M. J. Bown, "Differential MicroRNA expression profiles in peripheral arterial disease, " Circulation: Cardiovascular Genetics, vol. 6, no. 5, pp. 490-497, 2013.
36. F. Jansen, X. Yang, S. Proebsting et al., "MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease, " The Journal of the American Heart Association, vol. 3, no. 6, Article ID e001249, 2014.
37. S. Leptidis, H. el Azzouzi, S. I. Lok et al., "A deep sequencing approach to uncover the miRNOME in the human heart, " PLoS ONE, vol. 8, no. 2, Article ID e57800, pp. 1-9, 2013.
38. L.-L. Wang, Y. Huang, G. Wang, and S.-D. Chen, "The potential role of microRNA-146 in Alzheimers disease: biomarker or therapeutic target?" Medical Hypotheses, vol. 78, no. 3, pp. 398-401, 2012.
39. L. Tan, J.-T. Yu, Q.-Y. Liu et al., "Circulating miR-125b as a biomarker of Alzheimers disease, " Journal of the Neurological Sciences, vol. 336, no. 1-2, pp. 52-56, 2014.
40. N. Zhao, L. Jin, G. Fei, Z. Zheng, and C. Zhong, "Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinsons disease, " Parkinsonism and Related Disorders, vol. 20, no. 11, pp. 1177-1180, 2014.
41. A. K. Alieva, E. V. Filatova, A. V. Karabanov et al., "MiRNA expression is highly sensitive to a drug therapy in Parkinsons disease, " Parkinsonism and Related Disorders, vol. 21, no. 1, pp. 72-74, 2015.
42. J. Hazeldine, P. Hampson, and J.M. Lord, "The impact of trauma on neutrophil function, " Injury, vol. 45, no. 12, pp. 1824-1833, 2014.
43. N.-K. Liu, X.-F. Wang, Q.-B. Lu, and X.-M. Xu, "Altered microRNA expression following traumatic spinal cord injury, " Experimental Neurology, vol. 219, no. 2, pp. 424-429, 2009.
44. H. A. Shehab and Y. H. Nassar, "Neuromarkers as diagnostic adjuvant to cranial CT in closed traumatic brain injury patients admitted to ICU: a preliminary comparative study, " Egyptian Journal of Anaesthesia, vol. 26, no. 4, pp. 267-272, 2010.
45. B. Izumi, T. Nakasa, N. Tanaka et al., "MicroRNA-223 expression in neutrophils in the early phase of secondary damage after spinal cord injury, " Neuroscience Letters, vol. 492, no. 2, pp. 114-118, 2011.
46. P. Lei, Y. Li, X. Chen, S. Yang, and J. Zhang, "Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury, " Brain Research, vol. 1284, pp. 191-201, 2009.
47. C. C. Moore, I. H. McKillop, and T. Huynh, "MicroRNA expression following activated protein C treatment during septic shock, " Journal of Surgical Research, vol. 182, no. 1, pp. 116-126, 2013.
48. A. M. Piccinini and K. S. Midwood, "Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155, " Cell Reports, vol. 2, no. 4, pp. 914-926, 2012.
49. G. Reid, M. B. Kirschner, and N. van Zandwijk, "Circulating microRNAs: association with disease and potential use as biomarkers, " Critical Reviews in Oncology/Hematology, vol. 80, no. 2, pp. 193-208, 2011.
50. C. M. Comim, O. J. Cassol-Jr, L. S. Constantino et al., "Alterations in inflammatory mediators, oxidative stress parameters and energetic metabolism in the brain of sepsis survivor rats, " Neurochemical Research, vol. 36, no. 2, pp. 304-311, 2011.
51. J. C. Schefold, J. Bierbrauer, and S. Weber-Carstens, "Intensive care unit-Acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock, " Journal of Cachexia, Sarcopenia and Muscle, vol. 1, no. 2, pp. 147-157, 2010.
52. L.-X. Xie, "New biomarkers for sepsis, " Medical Journal of Chinese Peoples Liberation Army, vol. 38, no. 1, pp. 6-9, 2013.
53. C. A. Adams, "Sepsis biomarkers in polytrauma patients, " Critical Care Clinics, vol. 27, no. 2, pp. 345-354, 2011.
54. H. Wang, B. Yu, J. Deng, Y. Jin, and L. Xie, "Serum miR-122 correlates with short-Term mortality in sepsis patients, " Critical Care, vol. 18, no. 6, pp. 1-4, 2014.
55. J. Jacobi, "Pathophysiology of sepsis, " American Journal of Health-System Pharmacy, vol. 59, supplement 1, pp. 1435-1444, 2002.
56. S. Jadhav, R. Misra, C. Vyawahare, K. Angadi, N. Gandham, and P. Ghosh, "Role of sepsis screen in the diagnosis of neonatal sepsis, " Medical Journal of Dr. D.Y. Patil University, vol. 6, no. 3, pp. 254-257, 2013.
57. M. Bosmann and P. A. Ward, "The inflammatory response in sepsis, " Trends in Immunology, vol. 34, no. 3, pp. 129-136, 2013.
58. M. Huber-Lang, A. Kovtun, and A. Ignatius, "The role of complement in trauma and fracture healing, " Seminars in Immunology, vol. 25, no. 1, pp. 73-78, 2013.
59. L. Mica, J. Vomela, M. Keel, and O. Trentz, "The impact of bodymass index on the development of systemic inflammatory response syndrome and sepsis in patients with polytrauma, " Injury, vol. 45, no. 1, pp. 253-258, 2014.
60. E. Crimi, V. Sica, S. Williams-Ignarro et al., "The role of oxidative stress in adult critical care, " Free Radical Biology and Medicine, vol. 40, no. 3, pp. 398-406, 2006.
61. L. J. McGhan and D. E. Jaroszewski, "The role of toll-like receptor-4 in the development of multi-organ failure following traumatic haemorrhagic shock and resuscitation, " Injury, vol. 43, no. 2, pp. 129-136, 2012.
62. H. Tsujimoto, S. Ono, P. A. Efron, P. O. Scumpia, L. L. Moldawer, and H. Mochizuki, "Role of toll-like receptors in the development of sepsis, " Shock, vol. 29, no. 3, pp. 315-321, 2008.
63. H. Chen, E. Koustova, C. Shults, E. A. Sailhamer, and H. B. Alam, "Differential effect of resuscitation on Toll-like receptors in a model of hemorrhagic shock without a septic challenge, " Resuscitation, vol. 74, no. 3, pp. 526-537, 2007.
64. U. N. Das, "Serum adipocyte fatty acid-binding protein in the critically ill, " Critical Care, vol. 17, article 121, 2013.
65. F. R. Coelho and J. O. Martins, "Diagnostic methods in sepsis: the need of speed, " Revista da AssociacaoMedica Brasileira, vol. 58, no. 4, pp. 498-504, 2012.
66. E. Ii, "Biomarkers of sepsis, a never-ending story, " Jurnalul Roman de Anestezie Terapie Intensiva, vol. 21, no. 2, pp. 83-85, 2014.
67. F. Tacke, C. Roderburg, F. Benz et al., "Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients, " Critical Care Medicine, vol. 42, no. 5, pp. 1096-1104, 2014.
68. M. A. Puskarich, U. Nandi, N. I. Shapiro, S. Trzeciak, J. A. Kline, and A. E. Jones, "Detection of microRNAs in patients with sepsis, " Journal of Acute Disease, vol. 4, no. 2, pp. 101-106, 2015.
69. C. Vasilescu, S. Rossi, M. Shimizu et al., "MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis, " PLoS ONE, vol. 4, no. 10, Article IDe7405, 2009.
70. J.-F. Wang, M.-L. Yu, G. Yu et al., "Serum miR-146a and miR-223 as potential new biomarkers for sepsis, " Biochemical and Biophysical Research Communications, vol. 394, no. 1, pp. 184-188, 2010.
71. L. Wang, H.-C. Wang, C. Chen et al., "Differential expression of plasma miR-146a in sepsis patients compared with non-sepsis-SIRS patients, " Experimental and Therapeutic Medicine, vol. 5, no. 4, pp. 1101-1104, 2013.
72. F. Benz, F. Tacke, M. Luedde et al., "Circulating microRNA-223 serum levels do not predict sepsis or survival in patients with critical illness, " Disease Markers, vol. 2015, Article ID 384208, 10 pages, 2015.
73. Y. Ma, D. Vilanova, K. Atalar et al., "Genome-wide sequencing of cellular microRNAs identifies a combinatorial expression signature diagnostic of sepsis, " PLoS ONE, vol. 8, no. 10, Article ID e75918, 2013.
74. J. Huang, Z. Sun, W. Yan et al., "Identification of MicroRNA as sepsis biomarker based on miRNAs regulatory network analysis, " BioMed Research International, vol. 2014, Article ID 594350, 12 pages, 2014.
75. H.-L. Jia, C.-H. He, Z.-Y. Wang et al., "MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease, " BMC Infectious Diseases, vol. 14, no. 1, article 506, 2014.
76. F. Petrocca, R. Visone, M. R. Onelli et al., "E2F1-regulated microRNAs impair TGF-dependent cell-cycle arrest and apoptosis in gastric cancer, " Cancer Cell, vol. 13, no. 3, pp. 272-286, 2008.
77. P. Cossart and A. Lebreton, "A trip in the new microbiology with the bacterial pathogen Listeria monocytogenes, " FEBS Letters, vol. 588, no. 15, pp. 2437-2445, 2014.
78. L. Furci, E. Schena, P. Miotto, and D. M. Cirillo, "Alteration of human macrophages microRNA expression profile upon infection with Mycobacterium tuberculosis, " International Journal of Mycobacteriology, vol. 2, no. 3, pp. 128-134, 2013.
79. M. A. Davis, J. Y. Lim, Y. Soyer et al., "Development and validation of a resistance and virulence gene microarray targeting Escherichia coli and Salmonella enterica, " Journal of Microbiological Methods, vol. 82, no. 1, pp. 36-41, 2010.
80. W. Jin, E. M. Ibeagha-Awemu, G. Liang, F. Beaudoin, X. Zhao, and L. L. Guan, "Transcriptome microRNA profiling of bovine mammary epithelial cells challenged with Escherichia coli or Staphylococcus aureus bacteria reveals pathogen directed microRNA expression profiles, " BMC Genomics, vol. 15, no. 1, article 181, 2014.
81. K. Zheng, "Infection, " International Journal of Biological Sciences, p. 1013, 2012.
82. X. Zhou, X. Li, Y. Ye et al., "MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR/IRAK4 circuits, " Nature Communications, vol. 5, 2014.
83. L. L. Dai, J. X. Gao, C. G. Zou, Y. C. Ma, and K. Q. Zhang, "mir-233 modulates the unfolded protein response in C. elegans during Pseudomonas aeruginosa infection, " PLoS Pathogens, vol. 11, no. 1, Article ID e1004606, 2015.
84. C.-K. How, S.-K. Hou, H.-C. Shih et al., "Expression profile of MicroRNAs in gram-negative bacterial sepsis, " Shock, vol. 43, no. 2, pp. 121-127, 2015.
85. J. A. Weber, D. H. Baxter, S. Zhang et al., "The microRNA spectrum in 12 body fluids, " Clinical Chemistry, vol. 56, no. 11, pp. 1733-1741, 2010.
86. S. S. Silva, C. Lopes, A. L. Teixeira, M. J. C. D. Sousa, and R. Medeiros, "Forensic miRNA: potential biomarker for body fluids?" Forensic Science International: Genetics, vol. 14, pp. 1-10, 2015.
87. J. Ward, S. Bala, J. Petrasek, and G. Szabo, "Plasma microRNA profiles distinguish lethal injury in acetaminophen toxicity: a research study, " World Journal of Gastroenterology, vol. 18, no. 22, pp. 2798-2804, 2012.
88. E. K. Hanson, H. Lubenow, and J. Ballantyne, "Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs, " Analytical Biochemistry, vol. 387, no. 2, pp. 303-314, 2009.
89. D. Zubakov, A. W. M. Boersma, Y. Choi, P. F. van Kuijk, E. A. C. Wiemer, and M. Kayser, "MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation, " International Journal of Legal Medicine, vol. 124, no. 3, pp. 217-226, 2010.
90. C. Courts and B. Madea, "Micro-RNA-A potential for forensic science?" Forensic Science International, vol. 203, no. 1-3, pp. 106-111, 2010.
91. C. Courts and B. Madea, "Specific micro-RNA signatures for the detection of saliva and blood in forensic body-fluid identification, " Journal of Forensic Sciences, vol. 56, no. 6, pp. 1464-1470, 2011.
92. B. Gao, D. Wang, W. Ma et al., "MicroRNA-mRNA regulatory network study and apoptosis analysis on bone marrowendothelial cells induced by liver cirrhosis serum, " Clinics and Research in Hepatology and Gastroenterology, vol. 38, no. 4, pp. 451-461, 2014.
93. K. Essandoh and G.-C. Fan, "Role of extracellular and intracellular microRNAs in sepsis, " Biochimica et Biophysica Acta, vol. 1842, no. 11, pp. 2155-2162, 2014.
94. C. Haas, E. Hanson, and J. Ballantyne, Encyclopedia of Forensic Sciences, Elsevier, 2013.
95. M. Louise Hull and V. Nisenblat, "Tissue and circulating microRNA influence reproductive function in endometrial disease, " Reproductive BioMedicineOnline, vol. 27, no. 5, pp. 515-529, 2013.
96. M. Halimi, H. Parsian, S.M. Asghari et al., "Clinical translation of human microRNA 21 as a potential biomarker for exposure to ionizing radiation, " Translational Research, vol. 163, no. 6, pp. 578-584, 2014.
97. M. A. Elovitz, L. Anton, J. Bastek, and A. G. Brown, "Can microRNA profiling in maternal blood identify women at risk for pretermbirth, "AmericanJournal of Obstetrics&Gynecology, vol. 212, no. 6, pp. 782.e1-782.e5, 2015.
98. H. Wang, P. Zhang, W. Chen, D. Feng, Y. Jia, and L. Xie, "Serum microRNA signatures identified by Solexa sequencing predict sepsis patients mortality: a prospective observational study, " PLoS ONE, vol. 7, no. 6, Article ID e38885, pp. 1-9, 2012.
99. H. Wang, K. Meng, W. J. Chen, D. Feng, Y. Jia, and L. Xie, "Serum miR-574-5p: a prognostic predictor of sepsis patients, " Shock, vol. 37, no. 3, pp. 263-267, 2012.